Multistage inhibitors of the malaria parasite: Emerging hope for chemoprotection and malaria eradication

@article{Poonam2018MultistageIO,
  title={Multistage inhibitors of the malaria parasite: Emerging hope for chemoprotection and malaria eradication},
  author={Poonam and Yash Gupta and Nikesh Gupta and Snigdha Singh and Lidong Wu and Bhupender S Chhikara and Manmeet Rawat and Brijesh Rathi},
  journal={Medicinal Research Reviews},
  year={2018},
  volume={38},
  pages={1511 - 1535}
}
Over time, several exciting advances have been made in the treatment and prevention of malaria; however, this devastating disease continues to be a major global health problem and affects millions of people every year. Notably, the paucity of new efficient drug molecules and the inevitable drug resistance of the malaria parasite, Plasmodium falciparum, against frontline therapeutics are the foremost struggles facing malaria eradication initiatives. According to the malaria eradication agenda… Expand
18 Citations
Fast-Acting Small Molecules Targeting Malarial Aspartyl Proteases, Plasmepsins, Inhibit Malaria Infection at Multiple Life Stages.
TLDR
It is suggested that fast-acting hydroxyethylamine-phthalimide analogs targeting multiple life stages of the parasite could be a valuable chemical lead for the development of novel antimalarial drugs. Expand
Multistage antiplasmodial activity of hydroxyethylamine compounds, in vitro and in vivo evaluations
Malaria, a global threat to the human population, remains a challenge partly due to the fast-growing drug-resistant strains of Plasmodium species. New therapeutics acting against the pathogenicExpand
Screening Marine Natural Products for New Drug Leads against Trypanosomatids and Malaria
TLDR
This review presents critical updates regarding the use of High-Throughput Screening (HTS) in the discovery of drugs for NTDs transmitted by protozoa, including malaria, and its application in theiscovery of new drugs of marine origin. Expand
The emerging paradigm of calcium homeostasis as a new therapeutic target for protozoan parasites.
TLDR
It is suggested that the disruption of calcium homeostasis may be an effective approach to develop new anti-parasite drug candidates and reduce parasite resistance. Expand
Antiplasmodial activity of hydroxyethylamine analogs: Synthesis, biological activity and structure activity relationship of plasmepsin inhibitors.
TLDR
New C2 symmetric hydroxyethylamine analogs as the potential inhibitors of Plasmodium falciparum in in-vitro cultures are indicated and could serve as crucial for the development of new drug molecules. Expand
In silico validation of novel inhibitors of malarial aspartyl protease, plasmepsin V and antimalarial efficacy prediction.
TLDR
To decipher new inhibitors of Pf plasmepsin V, molecular docking of four HIV-1 protease inhibitors active against PfPlmV was performed on Glide module of Schrödinger suite that supported saquinavir as a lead drug, and therefore, selected as a control. Expand
Discovery of fast-acting dual-stage antimalarial agents by profiling pyridylvinylquinoline chemical space via copper catalyzed azide-alkyne cycloadditions.
TLDR
This study indicates that compound 60 is a fast-acting antimalarial compound and it demonstrates stage specific action at the trophozoite phase in the P. falciparum asexual life cycle, and shows good activity as an inhibitor of β-hematin formation. Expand
Fluorinated scaffolds for antimalarial drug discovery
TLDR
Selective fluorination of chemical entities has the potential to be applied not only to improve the activity profile against the malaria parasite, but could be extrapolated for favorable pharmacological applications. Expand
Differential Diagnosis and Possible Therapeutics for Coronavirus Disease 2019
TLDR
This book chapter deals with differential diagnosis in CO VID-19 and current knowledge of the possible therapeutics including herbal- or plant-based agents and plasma therapy for the treatment of COVID-19. Expand
Corona virus SARS-CoV-2 disease COVID-19: Infection, prevention and clinical advances of the prospective chemical drug therapeutics
TLDR
The epidemiology of COVID-19 infection, transmission characteristics of SARS-CoV-2 virus spread, effectiveness of preventive measures, coronavirus family, structural characteristics of virus, current literature advances for the diagnostics development and possible drug development based virus life cycle have been reviewed. Expand
...
1
2
...

References

SHOWING 1-10 OF 161 REFERENCES
The Next Opportunity in Anti-Malaria Drug Discovery: The Liver Stage
TLDR
Research on the frequency of differentially expressed genes in blood and liver stage parasites supports the feasibility of discovering stage-specific drugs for malaria, and requires a high-throughput liver stage phenotypic screen comparable to the existing blood stage screens. Expand
Drug discovery: Priming the antimalarial pipeline
TLDR
Two reports raise hopes that alternatives to artemisinins might be found, by identifying thousands of compounds inhibiting the growth of P. falciparum asexual-stage parasites in red blood cells, many distinct in structure and mechanism from current drugs. Expand
A High-Throughput Screen Targeting Malaria Transmission Stages Opens New Avenues for Drug Development
TLDR
This work has established and validated the first high-throughput assay targeting the red blood cell parasite stage required for transmission, the sexually reproducing gametocyte, and will permit identification of compounds specifically targeting the transmission stages in addition to the asexual stage parasites. Expand
Quinolone-3-Diarylethers: A New Class of Antimalarial Drug
TLDR
ELQ-300, a 4(1H)-quinolone-3-diarylether, which targets the liver and blood stages, including the forms that are crucial to disease transmission (gametocytes, zygotes, and ookinetes), has potential as a new drug for the treatment, prevention, and, ultimately, eradication of human malaria. Expand
Imaging of Plasmodium Liver Stages to Drive Next-Generation Antimalarial Drug Discovery
TLDR
An imidazolopiperazine scaffold series was identified that was highly enriched among compounds active against Plasmodium liver stages and shows potent in vivo blood-stage therapeutic activity. Expand
Inhibition of cytochrome bc1 as a strategy for single-dose, multi-stage antimalarial therapy.
TLDR
ELQ-400 is the first compound to provide combined treatment, prophylaxis, and transmission blocking activity for malaria after a single oral administration, and suggests that metabolic therapies, including cyt bc1 inhibitors, may be valuable additions to the collection of single-dose antimalarial treatment in current development. Expand
Design and Evaluation of Primaquine-Artemisinin Hybrids as a Multistage Antimalarial Strategy
TLDR
A novel approach to the design and evaluation of antimalarials based on the covalently linked primaquine and artemisinin moieties acting on different stages of the parasite life cycle is revealed. Expand
Thousands of chemical starting points for antimalarial lead identification
TLDR
Chemical structures and associated data suggest several novel mechanisms of antimalarial action, such as inhibition of protein kinases and host–pathogen interaction related targets. Expand
Targeting the hypnozoite reservoir of Plasmodium vivax: the hidden obstacle to malaria elimination.
TLDR
The only clinical therapy against relapse of vivax malaria is the 8-aminoquinoline, primaquine, which has the drawback of causing haemolysis in genetically sensitive patients and requires 14 days of treatment. Expand
Are Antimalarial Hybrid Molecules a Close Reality or a Distant Dream?
TLDR
This compilation is the first attempt to shed light on the shortcomings that are surfacing as more and more studies on molecular hybridization of the active pharmacophores of known antimalarials are being published. Expand
...
1
2
3
4
5
...